These correlations were not observed in group B. Conclusion: Injection of MSCs with marrow stimulation treatment was encouraging in patients older than 50 years compared with patients treated with marrow stimulation treatment alone, especially when the lesion size was larger than 109 mm(2) or a subchondral cyst existed. (researchgate.net)
The bone marrow-derived MSCs (BMSCs) were isolated by density gradient centrifugation. (biomedcentral.com)
Eight weeks after the establishment of the ONFH model, rats in BMSC-treated group and iPSC-MSC-treated group were implanted with BMSCs and iPSC-MSCs through intrabone marrow injection. (biomedcentral.com)
Furthermore, comparing the effectiveness of iPSC-MSCs and the normal BMSCs in an ONFH rat model revealed that the iPSC-MSCs was equivalent to normal BMSCs in preventing bone loss and promoting bone repair in the necrosis region of the femoral head. (biomedcentral.com)
Transplantation of iPSC-MSCs could effectively promote bone repair and angiogenesis in the necrosis area of the femoral head. (biomedcentral.com)
Stimulation3
Purpose: To compare the clinical outcomes of MSC injection and arthroscopic marrow stimulation treatment with those of arthroscopic marrow stimulation treatment alone for the treatment of OLTs in older patients. (researchgate.net)
Patients were divided into 2 groups: 35 patients (37 ankles) treated with arthroscopic marrow stimulation treatment alone (group A) and 30 patients (31 ankles) who underwent MSC injection along with arthroscopic marrow stimulation treatment (group B). Clinical outcomes were evaluated according to the visual analog scale (VAS) for pain, the American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot Scale, and the Roles and Maudsley score. (researchgate.net)
Current clinical procedures include bone marrow stimulation techniques, cartilage plug transplant, and expanded autologous chondrocyte implantation (Camp et al. (springeropen.com)
Clinical1
Biomedical Research and Therapy - Vietnamese Journal for Medical Biotechnology and Medicine Incorporating Advances in Regenerative Medicine publishes 12 peer-reviewed issues per year in all fields of biomedical and clinical sciences for internationally diverse authorship. (bmrat.org)
We bring together all the multiple myeloma experts you may need-offering dedicated highly specialized providers trained at the world's best academic medical centers-from hematology/medical oncology, immunology, stem cell transplantation, infectious diseases, pathology, radiation oncology, orthopedics, and nursing to provide you with a tailored plan of care based on the specific features of your disease and your personal condition. (sparkcures.com)
In the present study, the bone marrow samples of patients with ONFH ( n = 16) and patients with the fracture of the femoral neck ( n = 12) were obtained during operation. (biomedcentral.com)
Studies1
Dr Madan is a Professor in Health Economics at Warwick Medical School, and Director of Graduate Research Studies for the School. (warwick.ac.uk)
Center1
The treatment of multiple myeloma is highly personalized at John Theurer Cancer Center, part of Hackensack University Medical Center in New Jersey. (sparkcures.com)
Department1
history of the 1st pediatric department at the leningrad institute of advanced medical training]. (liverpool.ac.uk)
Chronic3
Each session contains four trials, with the exception of Saturday's, which has just two: the TRA 2°P trial, along with FOCUS , a new autologous bone-marrow stem-cell study in chronic heart failure. (medscape.com)
There is, however, no information on the use of autologous MSCs (autoMSCs), delivered intracerebrally in rats with a chronic infarct. (bvsalud.org)
These studies suggest that intracerebral transplantation of autoMSCs as compared to alloMSCs may be a promising treatment in chronic stroke. (bvsalud.org)
Patients2
With over 26 000 patients enrolled, the results of TRA 2°P "will be very impactful in clinical medicine," ACC program committee cochair Dr Patrick O'Gara (Brigham and Women's Hospital, Boston, MA) predicted. (medscape.com)
In her research, Olin has a particular interest in studying how best to treat blood cancers in older patients, some of whom may require a bone marrow transplant. (ucsfhealth.org)
Clinical1
She also has a master's degree in clinical epidemiology, with a focus on medical decision making, from the University of Pennsylvania. (ucsfhealth.org)
University2
Olin earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania and was elected to the Alpha Omega Alpha Honor Medical Society. (ucsfhealth.org)
Md. Mr. Charles J. Austin is Director of Computer Services and Assistant Professor of Preventive Medicine, University of Colorado Medical Center, Denver, Colorado. (nih.gov)